← FDA DRUG APPROVALS

FDA ANDA · ANDA074032

METOPROLOL TARTRATE

Sponsor: WATSON LABS

APPLICATION
ANDA074032
TYPE
ANDA
ORIGINAL APPROVAL
1993-12-21
LATEST ACTION
1999-02-02
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

METOPROLOL TARTRATEDiscontinued
METOPROLOL TARTRATE 1MG/ML · INJECTABLE · INJECTION

Approval history

1999-02-02Manufacturing (CMC) · Supplement 2AP
1998-08-19Manufacturing (CMC) · Supplement 4AP
1996-12-04Manufacturing (CMC) · Supplement 1AP
1993-12-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →